David Holtzman
15Patents
5h-index
24Co-inventors
66Inventor score
Filing activity: Dec 29, 2000 → Aug 24, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7195761B2 | Humanized antibodies that sequester abeta peptide | Chemistry; Metallurgy | 123 | Expired |
| US6465195B2 | Predictive diagnostic for Alzheimer's disease | Physics | 10 | Expired |
| US7771722B2 | Assay method for alzheimer's disease | Physics | 8 | Expired |
| US8232107B2 | Methods for measuring the metabolism of neurally derived biomolecules in vivo | Emerging Cross-Sectional Technologies | 5 | Active |
| US8591894B2 | Humanized antibodies that sequester amyloid beta peptide | Chemistry; Metallurgy | 5 | Active |
| US7892845B2 | Methods for measuring the metabolism of neurally dervied biomolecules in vivo | Emerging Cross-Sectional Technologies | 4 | Expired |
| US10830775B2 | Tau kinetic measurements | Human Necessities | 1 | Active |
| US11124562B2 | Anti-ApoE antibodies | Chemistry; Metallurgy | 1 | Active |
| US7892545B2 | Humanized antibodies that sequester amyloid beta peptide | Chemistry; Metallurgy | 1 | Active |
| US9834596B2 | Antibodies to tau | Physics | 1 | Active |
| US7015044B2 | Diagnostic for early stage Alzheimer's disease | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9453069B2 | Assay method for Alzheimer's disease | Physics | 0 | Active |
| US11926660B2 | Anti-ApoE antibodies | Chemistry; Metallurgy | 0 | Active |
| US12145988B2 | Anti-TREM-2 agonist antibodies | Chemistry; Metallurgy | 0 | Active |
| US8444977B2 | Assay method for Alzheimer's disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.